Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Breast Cancer Chemoprevention
NCT02781805Phase 1Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Aug 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of alendronate in breast cancer, sponsored by University of Wisconsin–Madison. Primary endpoint: Percentage change of γδ T cell in Core Needle Biopsy. Started Aug 2016; status: terminated.
02
Drugs
alendronate
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02781805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02781805.